Kazutoshi Cho
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kazutoshi Cho has a total of 100 co-authors. Here are the top co-authors by number of shared publications:
- Hisanori Minakami
Department of Obstetrics, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan
7 shared publications - Mamoru Morikawa
Department of Obstetrics and Gynecology, Kansai Medical University, Hirakata, Japan
6 shared publications Hisanori Minakami
Maternity and Perinatal Care Center, Hokkaido University Hospital, Sapporo 060-8648, Japan
5 shared publicationsTadashi Ariga
Department of Pediatrics, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo 060-8638, Japan
5 shared publicationsYosuke Kaneshi
Maternity and Perinatal Care Center, Hokkaido University Hospital, Sapporo, Japan
5 shared publicationsItaru Hayasaka
Maternity and Perinatal Care Center, Hokkaido University Hospital, Sapporo 060-8648, Japan
4 shared publications
Latest Publications
- 22 January 2026
- Published by Elsevier in Early Human Development
- Vol. 216, 106493
Genetic features of Japanese children with ABCA3 deficiency
- 22 January 2026
- Published by Elsevier in Early Human Development
- Vol. 216, 106493
Genetic features of Japanese children with ABCA3 deficiency
- 22 May 2025
- Published by Elsevier in Early Human Development
- Vol. 207, 106287
Genetic features of alveolar capillary dysplasia with misalignment of pulmonary veins in Japanese infants
- 22 May 2025
- Published by Elsevier in Early Human Development
- Vol. 207, 106287
Genetic features of alveolar capillary dysplasia with misalignment of pulmonary veins in Japanese infants
- 4 January 2024
- Published by Elsevier in Early Human Development
- Vol. 189, 105930
Neonatal-onset pulmonary alveolar proteinosis is a phenotype associated with poor outcomes in surfactant protein-C disorder
- 4 January 2024
- Published by Elsevier in Early Human Development
- Vol. 189, 105930
Neonatal-onset pulmonary alveolar proteinosis is a phenotype associated with poor outcomes in surfactant protein-C disorder
- 21 August 2021
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 181 (2) , 539-547
Risk factors for hospitalisation due to respiratory syncytial virus infection in children receiving prophylactic palivizumab
Respiratory syncytial virus (RSV) is a common pathogen that causes extremely severe respiratory symptoms in the first few weeks and months of life. In infants with cardiopulmonary diseases, RSV infections have a significant clinical impact. Palivizumab, a humanised monoclonal antibody for RSV, has been shown to significantly reduce the rate of hospitalisation of high-risk infants diagnosed with RSV. However, we have experienced a significant number of RSV infections in our institution that required hospitalisation or intensive care, despite the administration of palivizumab. This study aimed to analyse the risk factors associated with severe RSV despite the use of palivizumab. We retrospectively reviewed the medical records of 688 patients who visited or were admitted to our hospital and received palivizumab. Thirty-seven (5.4%) patients required hospitalisation for RSV, despite receiving palivizumab. In addition, 31 of these patients (83.8%) required hospitalisation out of season for palivizumab injection. Preterm birth (≤ 28-week gestation), bronchopulmonary dysplasia (BPD), and trisomy 21 were risk factors for RSV-related hospitalisation in infected patients, despite receiving palivizumab. Furthermore, subgroup analysis of 69 patients with RSV revealed that hemodynamically significant congenital heart disease (CHD) was also a risk factor for RSV-related hospitalisation. Conclusion: Preterm birth (≤ 28 weeks of gestation), BPD, trisomy 21, hemodynamically significant CHD, and CHD requiring surgery or cardiac catheterisation/intervention during infancy could be considered when determining whether year-round administration of palivizumab is appropriate. What is Known: • Respiratory syncytial virus causes severe respiratory symptoms in infants, particularly those with cardiopulmonary diseases. • The use of palivizumab has reduced the rate of hospitalisation of infants diagnosed with RSV. Despite this, the rate of hospitalisation is still high. What is New: • We identified that preterm birth (≤ 28-week gestation), bronchopulmonary dysplasia, trisomy 21, and hemodynamically significant congenital heart disease were risk factors for RSV-related hospitalisation, even after receiving palivizumab treatment. • High-risk infants should be closely monitored and the prolonged use of palivizumab should be considered.
- 21 August 2021
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 181 (2) , 539-547
Risk factors for hospitalisation due to respiratory syncytial virus infection in children receiving prophylactic palivizumab
Respiratory syncytial virus (RSV) is a common pathogen that causes extremely severe respiratory symptoms in the first few weeks and months of life. In infants with cardiopulmonary diseases, RSV infections have a significant clinical impact. Palivizumab, a humanised monoclonal antibody for RSV, has been shown to significantly reduce the rate of hospitalisation of high-risk infants diagnosed with RSV. However, we have experienced a significant number of RSV infections in our institution that required hospitalisation or intensive care, despite the administration of palivizumab. This study aimed to analyse the risk factors associated with severe RSV despite the use of palivizumab. We retrospectively reviewed the medical records of 688 patients who visited or were admitted to our hospital and received palivizumab. Thirty-seven (5.4%) patients required hospitalisation for RSV, despite receiving palivizumab. In addition, 31 of these patients (83.8%) required hospitalisation out of season for palivizumab injection. Preterm birth (≤ 28-week gestation), bronchopulmonary dysplasia (BPD), and trisomy 21 were risk factors for RSV-related hospitalisation in infected patients, despite receiving palivizumab. Furthermore, subgroup analysis of 69 patients with RSV revealed that hemodynamically significant congenital heart disease (CHD) was also a risk factor for RSV-related hospitalisation. Conclusion: Preterm birth (≤ 28 weeks of gestation), BPD, trisomy 21, hemodynamically significant CHD, and CHD requiring surgery or cardiac catheterisation/intervention during infancy could be considered when determining whether year-round administration of palivizumab is appropriate. What is Known: • Respiratory syncytial virus causes severe respiratory symptoms in infants, particularly those with cardiopulmonary diseases. • The use of palivizumab has reduced the rate of hospitalisation of infants diagnosed with RSV. Despite this, the rate of hospitalisation is still high. What is New: • We identified that preterm birth (≤ 28-week gestation), bronchopulmonary dysplasia, trisomy 21, and hemodynamically significant congenital heart disease were risk factors for RSV-related hospitalisation, even after receiving palivizumab treatment. • High-risk infants should be closely monitored and the prolonged use of palivizumab should be considered.
- 1 March 2018
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 102 (3) , 480-486
Heterozygous Mutations in OAS1 Cause Infantile-Onset Pulmonary Alveolar Proteinosis with Hypogammaglobulinemia
- 1 March 2018
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 102 (3) , 480-486
Heterozygous Mutations in OAS1 Cause Infantile-Onset Pulmonary Alveolar Proteinosis with Hypogammaglobulinemia
- Open Access
- 21 February 2018
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 15 (2) , 369
Different Risk Factors for Very Low Birth Weight, Term-Small-for-Gestational-Age, or Preterm Birth in Japan
From 1985 to 2013, the mean birth weight of infants in Japan decreased from 3120 g to 3000 g, and the low-birth-weight rate among live births increased from 6.3% to 9.6%. No prospective study has elucidated the risk factors for poor fetal growth and preterm birth in recent Japanese parents, such as increased parental age, maternal body figure, assisted reproductive technology (ART), and socioeconomic status. Participants were mother–infant pairs (n = 18,059) enrolled in a prospective birth cohort in Hokkaido, Japan from 2002 to 2013. Parental characteristics were obtained via self-reported questionnaires during pregnancy. Medical records helped identify very-low-birth-weight (VLBW; 2 increased the risk of PTB and term-SGA. The RR for low BMI was highest among mothers who have low educational level. Among various factors, appropriate nutritional education to maintain normal BMI is important to prevent PTB and term-SGA in Japan.
- 21 February 2018
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 15 (2) , 369
Open AccessDifferent Risk Factors for Very Low Birth Weight, Term-Small-for-Gestational-Age, or Preterm Birth in Japan
From 1985 to 2013, the mean birth weight of infants in Japan decreased from 3120 g to 3000 g, and the low-birth-weight rate among live births increased from 6.3% to 9.6%. No prospective study has elucidated the risk factors for poor fetal growth and preterm birth in recent Japanese parents, such as increased parental age, maternal body figure, assisted reproductive technology (ART), and socioeconomic status. Participants were mother–infant pairs (n = 18,059) enrolled in a prospective birth cohort in Hokkaido, Japan from 2002 to 2013. Parental characteristics were obtained via self-reported questionnaires during pregnancy. Medical records helped identify very-low-birth-weight (VLBW; 2 increased the risk of PTB and term-SGA. The RR for low BMI was highest among mothers who have low educational level. Among various factors, appropriate nutritional education to maintain normal BMI is important to prevent PTB and term-SGA in Japan.
- Open Access
- 1 November 2017
- Published by Springer Nature in Pediatric Research
- Vol. 83 (2) , 477-483
Genetic basis for childhood interstitial lung disease among Japanese infants and children
- 1 November 2017
- Published by Springer Nature in Pediatric Research
- Vol. 83 (2) , 477-483
Open AccessGenetic basis for childhood interstitial lung disease among Japanese infants and children
- 17 December 2016
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 43 (3) , 505-510
Frequency of malformed infants in a tertiary center in Hokkaido, Japan over a period of 10 years
Aim: This retrospective study was performed to determine the frequency of malformed infants born at a tertiary center in Hokkaido, Japan. The accuracy of prenatal diagnosis rates was also investigated.Methods: An observational study was performed using data of 1509 and 1743 newborn infants at a single center during two study periods, 2005–2009 (first) and 2010–2014 (second), respectively. Cases including minor anomalies (accessory auricle, nevus and fistula auris congenita) were not included.Results: In total, 274 and 569 malformations were identified in 191 and 337 newborn infants in the first and second study periods, respectively. The number of malformed infants increased significantly over time (13% [191/1509] vs 19% [337/1743], respectively; P < 0.001), mainly as a result of an increase in cases of congenital heart disease (CHD), from 59 to 141 (31% [59/191] vs 42% [141/337] of all malformed infants in the first and second periods, respectively). The overall accurate prenatal diagnosis rate improved over time from 47% (128/274) to 58% (329/569) because of significant improvements in accurate prenatal diagnosis of CHD subtypes (23% [16/70] vs 65% [151/232] in the first and second periods, respectively, P < 0.0001).Conclusions: The frequency of malformed newborns was higher in the tertiary center than in the general population. The increased number of cases with prenatal suspicion and diagnosis of CHD contributed to the increased frequency of malformed infants during the study period.
- 17 December 2016
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 43 (3) , 505-510
Frequency of malformed infants in a tertiary center in Hokkaido, Japan over a period of 10 years
Aim: This retrospective study was performed to determine the frequency of malformed infants born at a tertiary center in Hokkaido, Japan. The accuracy of prenatal diagnosis rates was also investigated.Methods: An observational study was performed using data of 1509 and 1743 newborn infants at a single center during two study periods, 2005–2009 (first) and 2010–2014 (second), respectively. Cases including minor anomalies (accessory auricle, nevus and fistula auris congenita) were not included.Results: In total, 274 and 569 malformations were identified in 191 and 337 newborn infants in the first and second study periods, respectively. The number of malformed infants increased significantly over time (13% [191/1509] vs 19% [337/1743], respectively; P < 0.001), mainly as a result of an increase in cases of congenital heart disease (CHD), from 59 to 141 (31% [59/191] vs 42% [141/337] of all malformed infants in the first and second periods, respectively). The overall accurate prenatal diagnosis rate improved over time from 47% (128/274) to 58% (329/569) because of significant improvements in accurate prenatal diagnosis of CHD subtypes (23% [16/70] vs 65% [151/232] in the first and second periods, respectively, P < 0.0001).Conclusions: The frequency of malformed newborns was higher in the tertiary center than in the general population. The increased number of cases with prenatal suspicion and diagnosis of CHD contributed to the increased frequency of malformed infants during the study period.
- Open Access
- 30 September 2015
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 41 (12) , 1988-1990
Decreased baseline variability on fetal heart rate pattern in a fetus with heterotaxy syndrome
- 30 September 2015
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 41 (12) , 1988-1990
Open AccessDecreased baseline variability on fetal heart rate pattern in a fetus with heterotaxy syndrome
- 22 April 2015
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 174 (8) , 1123-1126
A late presenter and long-term survivor of alveolar capillary dysplasia with misalignment of the pulmonary veins
This report demonstrates a late presenter and long-term survivor (38 months old) of alveolar capillary dysplasia with misalignment of the pulmonary veins (ACD/MPV) and with a heterozygous frameshift mutation in FOXF1. The mild phenotype may be due to his residual normal lung tissue as demonstrated in the chest computed tomography (CT) and histopathological findings. Conclusion: We report the longest survivor of ACD/MPV. The mild phenotype is most likely due to the patient’s residual normal lung tissue.
- 22 April 2015
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 174 (8) , 1123-1126
A late presenter and long-term survivor of alveolar capillary dysplasia with misalignment of the pulmonary veins
This report demonstrates a late presenter and long-term survivor (38 months old) of alveolar capillary dysplasia with misalignment of the pulmonary veins (ACD/MPV) and with a heterozygous frameshift mutation in FOXF1. The mild phenotype may be due to his residual normal lung tissue as demonstrated in the chest computed tomography (CT) and histopathological findings. Conclusion: We report the longest survivor of ACD/MPV. The mild phenotype is most likely due to the patient’s residual normal lung tissue.